Page last updated: 2024-08-16

ticlopidine and 11-dehydro-thromboxane b2

ticlopidine has been researched along with 11-dehydro-thromboxane b2 in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (80.00)	29.6817
2010's	1 (20.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bang, NU; Bruno, A; Cohen, SN; Gorelick, PB; McConnell, JP; Tietjen, GE; Wallis, RA	1
Hjemdahl, P; Hu, H; Li, N; Perneby, C; Wallén, NH	1
Fitzgerald, DJ; Maree, AO	1
Brace, LD; Cursio, J; Grossi, E; Helgason, CM; Pandey, D; Valika, A	1
Eikelboom, JW; Hirsh, J; Johnston, MA; Li, C; Xie, C	1

Reviews

1 review(s) available for ticlopidine and 11-dehydro-thromboxane b2

Article	Year
Variable platelet response to aspirin and clopidogrel in atherothrombotic disease. Circulation, 2007, Apr-24, Volume: 115, Issue:16 Topics: Adenosine Diphosphate; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Atherosclerosis; Biomarkers; Biotransformation; Blood Coagulation Tests; Blood Platelets; Cardiovascular Diseases; Clopidogrel; Cyclooxygenase 1; Cyclooxygenase Inhibitors; Drug Interactions; Drug Resistance; Hemorrhage; Humans; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Randomized Controlled Trials as Topic; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y12; Thrombosis; Thromboxane A2; Thromboxane B2; Ticlopidine; Treatment Failure	2007

Article

Year

Variable platelet response to aspirin and clopidogrel in atherothrombotic disease.

Circulation, 2007, Apr-24, Volume: 115, Issue:16

Topics: Adenosine Diphosphate; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Atherosclerosis; Biomarkers; Biotransformation; Blood Coagulation Tests; Blood Platelets; Cardiovascular Diseases; Clopidogrel; Cyclooxygenase 1; Cyclooxygenase Inhibitors; Drug Interactions; Drug Resistance; Hemorrhage; Humans; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Randomized Controlled Trials as Topic; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y12; Thrombosis; Thromboxane A2; Thromboxane B2; Ticlopidine; Treatment Failure

2007

Trials

4 trial(s) available for ticlopidine and 11-dehydro-thromboxane b2

Article	Year
Serial urinary 11-dehydrothromboxane B2, aspirin dose, and vascular events in blacks after recent cerebral infarction. Stroke, 2004, Volume: 35, Issue:3 Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Black People; Cerebral Infarction; Dose-Response Relationship, Drug; Double-Blind Method; Drug Resistance; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pilot Projects; Platelet Aggregation Inhibitors; Predictive Value of Tests; Recurrence; Risk Factors; Thromboxane B2; Ticlopidine	2004
Prothrombotic responses to exercise are little influenced by clopidogrel treatment. Thrombosis research, 2004, Volume: 114, Issue:4 Topics: Adenosine Diphosphate; Adult; Blood Platelets; Cell Adhesion; Clopidogrel; Cross-Over Studies; Exercise; Humans; Leukocytes; Male; P-Selectin; Platelet Aggregation; Platelet Aggregation Inhibitors; Thrombophilia; Thromboxane B2; Ticlopidine	2004
Platelet aggregation and recruitment with aspirin-clopidogrel therapy. Cerebrovascular diseases (Basel, Switzerland), 2008, Volume: 25, Issue:5 Topics: Aspirin; Brain Ischemia; Clopidogrel; Cohort Studies; Drug Therapy, Combination; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Stroke; Thromboxane B2; Ticlopidine	2008
Reversal of the anti-platelet effects of aspirin and clopidogrel. Journal of thrombosis and haemostasis : JTH, 2012, Volume: 10, Issue:4 Topics: Adenosine Diphosphate; Adult; Arachidonic Acid; Aspirin; Biomarkers; Blood Platelets; Clopidogrel; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Ontario; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Platelet Transfusion; Recovery of Function; Thromboxane B2; Ticlopidine; Time Factors	2012